TUDEYRO
LIVE

Serial Number

97720683

Owner

Novartis AG

Attorney

Maury M. Tepper, III

Filing Date

Dec 16, 2022

Add to watchlist:

No watchlists yet
View on USPTO

TUDEYRO Trademark

Serial Number: 97720683

TUDEYRO is a trademark filed by Novartis AG on December 16, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Novartis AG (12 trademarks)

CH-4002 Basel

Entity Type: 03

Trademark Details

Filing Date

December 16, 2022

Registration Date

Not Registered

Published for Opposition

July 18, 2023

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

SOU TEAS EXTENSION RECEIVED
Mar 3, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 15, 2025 EXRA
SOU EXTENSION 4 GRANTED
Sep 6, 2025 EX4G
SOU EXTENSION 4 FILED
Sep 6, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Sep 6, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 11, 2025 EXRA
SOU EXTENSION 3 GRANTED
Mar 11, 2025 EX3G
SOU EXTENSION 3 FILED
Mar 10, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Mar 10, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 9, 2024 EXRA
SOU EXTENSION 2 GRANTED
Sep 9, 2024 EX2G
SOU EXTENSION 2 FILED
Sep 9, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Sep 9, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 9, 2024 EXRA
SOU EXTENSION 1 GRANTED
Mar 8, 2024 EX1G
SOU EXTENSION 1 FILED
Mar 8, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 8, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 12, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 18, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jul 18, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 28, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 15, 2023 CNSA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 14, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jun 14, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jun 14, 2023 CNRT
ASSIGNED TO EXAMINER
Jun 12, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 12, 2023 NWOS
NEW APPLICATION ENTERED
Dec 20, 2022 NWAP